Search clinical trials for: calcimimetic agent
Total 188766 results
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Not yet recruiting
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingKidney Failure, Chronic | Chronic Kidney Disease-Mineral and Bone DisorderUnited States
-
Xiaoyan JiaRecruitingChronic Kidney Disease-Mineral and Bone DisorderChina
-
VA Office of Research and DevelopmentUniversity of California, San FranciscoRecruiting
-
Kyowa Kirin China Pharmaceutical Co., Ltd.CompletedHyperparathyroidism; Secondary, RenalChina
-
Tanta UniversityCompleted
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Active, not recruiting
-
Brigham and Women's HospitalCompletedPrimary HyperparathyroidismUnited States
-
Hartmut Malluche, MDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Wright...Completed
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism
-
Astellas Pharma IncCompletedSecondary HyperparathyroidismJapan
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.CompletedSecondary HyperparathyroidismChina, Hong Kong, Korea, Republic of, Taiwan
-
The University of Hong KongCompletedVascular Diseases | Secondary Hyperparathyroidism | Kidney FailureHong Kong
-
Peter VestergaardAalborg UniversityCompletedPrimary Hyperparathyroidism | Parathyroid Adenoma | Parathyroid HyperplasiaDenmark
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, Taiwan, Hong Kong, China, India, Malaysia
-
Montefiore Medical CenterTerminatedRenal Transplant | HypophosphatemiaUnited States
-
Montefiore Medical CenterTerminatedSecondary Hyperparathyroidism | HypercalcemiaUnited States
-
Children's Mercy Hospital Kansas CityCompletedHypophosphatemic Rickets, X-Linked DominantUnited States
-
Children's Mercy Hospital Kansas CityWithdrawn
-
Min-Sheng General HospitalTaipei Medical University; Taipei Medical University Shuang Ho Hospital; National... and other collaboratorsCompletedHyperparathyroidism; Secondary, RenalTaiwan
-
AmgenCompletedSecondary Hyperparathyroidism, Chronic Kidney DiseaseUnited States, Czechia, Germany, France, Hungary, Greece, Belgium, Italy, Poland, Russian Federation, Ukraine
-
AmgenTerminatedChronic Kidney Disease, Secondary HyperparathyroidismUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Greece, Spain, Poland, Russian Federation, Ukraine, New Zealand, Slovakia, Lithuania, Portugal
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AmgenTerminatedChronic Kidney Disease | Hyperparathyroidism, SecondaryUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, SecondaryUnited States, Germany, United Kingdom
-
Centre Hospitalier Universitaire VaudoisSwiss National Science FoundationCompletedRelationship Between Calcimimetic and the RAASSwitzerland
-
Karolinska University HospitalKarolinska InstitutetUnknownPrimary HyperparathyroidismSweden
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
AmgenCompleted
-
AmgenCompletedPrimary Hyperparathyroidism
-
Astellas Pharma IncCompletedPatients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy | Pharmacodynamics of ASP7991 | Pharmacokinetics of ASP7991Japan
-
AmgenCompletedHyperparathyroidism, Primary | HypercalcemiaUnited States, Canada, Russian Federation, Hungary, Australia, Portugal, Poland
-
AmgenCompleted
-
AmgenCompletedHyperparathyroidism | End Stage Renal Disease | Chronic Kidney Disease | Kidney Transplantation | Chronic Renal Failure | Hypophosphatemia | Kidney Disease | Chronic Allograft Nephropathy | Disordered Mineral Metabolism | Post Renal TransplantationUnited States, Canada, France, Italy, Belgium, Switzerland, Spain, Australia, Germany, Austria, Poland
-
AmgenCompleted
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the ProstateUnited States
-
Kyowa Kirin Co., Ltd.CompletedPrimary Hyperparathyroidism | Parathyroid Carcinoma | HypercalcemiaJapan
-
University of Colorado, DenverCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
Centre Hospitalier Universitaire, AmiensTerminatedHemodialysis | Chronic Renal FailureFrance
-
Josep M CruzadoCompletedSecondary HyperparathyroidismSpain
-
Istituto Auxologico ItalianoCompletedHyperparathyroidism, Primary | OsteoporosisItaly
-
Penang Hospital, MalaysiaMinistry of Health, MalaysiaUnknownSecondary HyperparathyroidismMalaysia
-
Papageorgiou General HospitalTerminatedSecondary HyperparathyroidismGreece
-
AmgenCompletedCardiovascular Disease | Hyperparathyroidism | End Stage Renal Disease | Chronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Coronary Artery Calcification | Vascular Calcification | Kidney Disease | Calcification | Nephrology
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
Laval UniversityAmgenCompletedChronic Kidney DiseaseCanada
-
AmgenCompletedSecondary Hyperparathyroidism